The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Seclaris DC 250 mg Intramammary Suspension for dry cows

Ceva Santé AnimaleVPA10815/047/001

Main Information

Trade NameSeclaris DC 250 mg Intramammary Suspension for dry cows
Active SubstancesCefalonium dihydrate
Dosage FormIntramammary suspension
Licence HolderCeva Santé Animale
License Holder Address10, avenue de La Ballastière
33500 Libourne
Licence NumberVPA10815/047/001

Group Information

ATC CodeQJ51DB90 cefalonium
Therapeutic ClassAntibacterial


License statusWithdrawn
Withdrawn Date10/06/2024
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back